Internal Medicine News - Generic Lamictal approved
Generic Lamictal (lamotrigine, 5-mg and 25-mg tablets) is approved for adjunctive therapy for partial seizures in adults and pediatric patients aged 2 years and older. The drug is also indicated as adjunctive therapy for the generalized seizures of Lennox-Gastaut syndrome in adult and pediatric patients aged 2 years and older.
Related Results
LamictalGSK launches LamictalStudy backs Lamictal XRLamictal:Lamictal
For more information, contact TEVA Pharmaceuticals USA by calling 888-838-2872 or 215-591-3000.
COPYRIGHT 2006 International Medical News Group
COPYRIGHT 2008 Gale, Cengage Learning
